Welcome to LookChem.com Sign In|Join Free

CAS

  • or

13907-45-4

Post Buying Request

13907-45-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

13907-45-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 13907-45-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,3,9,0 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 13907-45:
(7*1)+(6*3)+(5*9)+(4*0)+(3*7)+(2*4)+(1*5)=104
104 % 10 = 4
So 13907-45-4 is a valid CAS Registry Number.
InChI:InChI=1/Cr.4O/q;;;2*-1/rCrO4/c2-1(3,4)5/q-2

13907-45-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name chromate(VI) ion

1.2 Other means of identification

Product number -
Other names DIOXIDO(DIOXO)CHROMIUM

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:13907-45-4 SDS

13907-45-4Relevant articles and documents

Hydrolytic and redox transformations of chromium(III) bis-oxalato complexes with glutaminic acid and glutamine: A kinetic, UV-Vis and EPR, study

Kiersikowska, Emilia,Kita, Ewa,Kita, Przemys?aw,Wrzeszcz, Grzegorz

, p. 435 - 445 (2016/04/19)

The title complexes have been synthesized, chromatographically isolated and characterized by their ligands to metal ratio determinations and spectroscopic analyses. The kinetics of the first aquation stage, i.e., the amino acid chelate ring opening via the Cr-N bond cleavage, has been studied spectrophotometrically in acidic and alkaline media. Hydrogen peroxide oxidizes the complexes in alkaline media to CrO 42- anion and a relatively stable Cr(V) complex. Consecutive biphasic kinetics through two first-order steps were observed for the base hydrolysis and the oxidation process, whereas the acid-catalyzed aquation obeys a simple first-order pattern. Based on the kinetic and spectroscopic data, mechanisms of the coordinated amino acid liberation and chromium(III) oxidation are discussed.

Chromium(V) peptide complexes: Synthesis and spectroscopic characterization

Barnard, Peter J.,Levina, Aviva,Lay, Peter A.

, p. 1044 - 1053 (2008/10/09)

A series of stable Cr(V) model complexes that mimic the binding of Cr(V) to peptide backbones at the C-terminus of proteins have been prepared for N,N-dimethylurea derivatives of the tripeptides Aib3-DMF, AibLAlaAib-DMF, and AibDAlaAib-DMF (Aib = 2-amino-2-methylpropanoic acid, DMF = N,N-dimethylformamide). The Cr(II) precursor complexes were synthesized by the initial deprotonation of the amide and acid groups of the peptide ligands in DMF with potassium tert-butoxide in the presence of CrCl2. The Cr(II) intermediates thus formed were then immediately oxidized to Cr(V) using tert-butyl hydroperoxide. Spectroscopic and mass-spectrometric analyses of the Cr(V) complexes showed that a new metal-directed organic transformation of the ligand had occurred. This involved a DMF solvent molecule becoming covalently bound to the amine group of the peptide ligand, yielding a urea group, and a third coordinated deprotonated urea nitrogen donor. A metal-directed oxidative coupling has been proposed as a possible mechanism for the organic transformation. The Cr(V/IV) reduction potential was determined for the three Cr(V) complexes using cyclic voltammetry, and in all cases it was quasi-reversible. These are the first isolated and fully characterized Cr(V) complexes with non-sulfur-containing peptide ligands.

Biomimetic oxidation of chromium(III): Does the antidiabetic activity of chromium(III) involve carcinogenic chromium(VI)?

Mulyani, Irma,Levina, Aviva,Lay, Peter A.

, p. 4504 - 4507 (2007/10/03)

The insulin-enhancing activities of some CrIII complexes, such as [Cr3O(OCOEt)6-(OH2)3]+ (1), previously attributed to specific interactions of CrIII ions with cellular insulin receptors, are more likely to be caused by the formation of [CrO4]2- (2). Oxidation of 1 to 2 by biologically relevant oxidants, including enzymes (see scheme), and inhibition of an isolated protein tyrosine phosphatase by a CrVI complex are reported.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 13907-45-4